Pfizer Ltd. | Large-cap | Healthcare
₹5,698.00
0.36%
| Pfizer Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 22.8B
Gross Profit 14.7B 64.47%
Operating Income 6.8B 29.78%
Net Income 7.7B 33.65%

Balance Sheet Metrics

Total Assets 49.1B
Total Liabilities 6.9B
Shareholders Equity 42.2B
Debt to Equity 0.16

Cash Flow Metrics

Operating Cash Flow 9.1B
Free Cash Flow 6.3B

Revenue & Profitability Trend

Pfizer Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 22.8B 21.9B 24.2B 26.1B 22.4B
Cost of Goods Sold 8.1B 8.0B 8.8B 9.5B 8.0B
Gross Profit 14.7B 14.0B 15.5B 16.6B 14.4B
Operating Expenses 3.6B 4.1B 4.0B 7.0B 3.6B
Operating Income 6.8B 5.8B 7.1B 7.2B 6.1B
Pre-tax Income 10.2B 7.5B 8.2B 7.7B 6.7B
Income Tax 2.5B 1.9B 2.0B 1.6B 1.7B
Net Income 7.7B 5.5B 6.2B 6.1B 5.0B
EPS (Diluted) - ₹120.51 ₹136.38 ₹133.89 ₹108.77

Income Statement Trend

Pfizer Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 35.1B 27.7B 25.3B 24.0B 19.1B
Non-Current Assets 14.0B 14.6B 14.8B 15.0B 13.6B
Total Assets 49.1B 42.3B 40.0B 39.0B 32.7B
Liabilities
Current Liabilities 5.7B 5.5B 6.6B 8.5B 7.7B
Non-Current Liabilities 1.2B 866.8M 1.4B 1.8B 985.2M
Total Liabilities 6.9B 6.3B 7.9B 10.4B 8.7B
Equity
Total Shareholders Equity 42.2B 36.0B 32.1B 28.6B 23.9B

Balance Sheet Composition

Pfizer Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 10.2B 7.5B 8.2B 7.7B 6.7B
Operating Cash Flow 9.1B 4.5B 8.1B 7.9B 6.6B
Investing Activities
Capital Expenditures 1.2B 339.7M -637.6M -132.5M -176.2M
Investing Cash Flow 1.4B 341.2M 1.2B -6.2B -5.1B
Financing Activities
Dividends Paid -1.6B -1.8B -3.0B -1.6B -15.2B
Financing Cash Flow -1.6B -1.8B -3.0B -1.6B -15.2B
Free Cash Flow 6.3B 2.4B 2.9B 6.5B 4.1B

Cash Flow Trend

Pfizer Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 33.66
Forward P/E 33.69
Price to Book 6.12
Price to Sales 11.31
PEG Ratio 33.69

Profitability Ratios

Profit Margin 33.65%
Operating Margin 35.66%
Return on Equity 19.65%
Return on Assets 9.29%

Financial Health

Current Ratio 6.17
Debt to Equity 2.57
Beta 0.18

Per Share Data

EPS (TTM) ₹167.54
Book Value per Share ₹921.88
Revenue per Share ₹498.68

Financial data is updated regularly. All figures are in the company's reporting currency.